000518 四环生物
已收盘 10-27 15:00:00
资讯
新帖
简况
四环生物（000518）10月23日主力资金净卖出1037.71万元
证券之星 · 10-23
四环生物（000518）10月23日主力资金净卖出1037.71万元
四环生物（000518）10月21日主力资金净买入5402.45万元
证券之星 · 10-21
四环生物（000518）10月21日主力资金净买入5402.45万元
异动快报：四环生物（000518）10月21日11点13分触及涨停板
证券之星 · 10-21
异动快报：四环生物（000518）10月21日11点13分触及涨停板
股市必读：四环生物新发布《江苏四环生物股份有限公司关于收购吉林省长源药业有限公司部分股权的进展公告》
证券之星 · 10-19
股市必读：四环生物新发布《江苏四环生物股份有限公司关于收购吉林省长源药业有限公司部分股权的进展公告》
四环生物（000518）披露收购长源药业部分股权进展公告，10月16日股价下跌2.08%
证券之星 · 10-16
四环生物（000518）披露收购长源药业部分股权进展公告，10月16日股价下跌2.08%
股市必读：四环生物新发布《江苏四环生物股份有限公司关于收购中润药业有限公司部分股权的进展公告》
证券之星 · 10-14
股市必读：四环生物新发布《江苏四环生物股份有限公司关于收购中润药业有限公司部分股权的进展公告》
四环生物（000518）10月12日主力资金净卖出2657.70万元
证券之星 · 10-12
四环生物（000518）10月12日主力资金净卖出2657.70万元
股市必读：四环生物新发布《四环生物2026年第三次临时股东会法律意见书》
证券之星 · 10-12
股市必读：四环生物新发布《四环生物2026年第三次临时股东会法律意见书》
四环生物（000518）披露关于收购吉林省长源药业有限公司部分股权的议案获通过，10月09日股价下跌1.1%
证券之星 · 10-09
四环生物（000518）披露关于收购吉林省长源药业有限公司部分股权的议案获通过，10月09日股价下跌1.1%
四环生物（000518）9月28日主力资金净买入729.07万元
证券之星 · 09-28
四环生物（000518）9月28日主力资金净买入729.07万元
四环生物：第十一届董事会第五次会议决议公告
证券日报网 · 09-23
四环生物：第十一届董事会第五次会议决议公告
四环生物最新公告：拟1.6亿元收购长源药业80%股权
证券之星 · 09-23
四环生物最新公告：拟1.6亿元收购长源药业80%股权
股市必读：四环生物新发布《四环生物2026年第二次临时股东会法律意见书》
证券之星 · 09-23
股市必读：四环生物新发布《四环生物2026年第二次临时股东会法律意见书》
四环生物（000518）披露收购中润药业部分股权议案获临时股东大会通过，9月22日股价下跌2.33%
证券之星 · 09-22
四环生物（000518）披露收购中润药业部分股权议案获临时股东大会通过，9月22日股价下跌2.33%
四环生物：公司将于2026年9月21日召开2026年第二次临时股东会
证券日报网 · 09-04
四环生物：公司将于2026年9月21日召开2026年第二次临时股东会
四环生物最新公告：拟1.6亿元收购中润药业65.61%股权
证券之星 · 09-04
四环生物最新公告：拟1.6亿元收购中润药业65.61%股权
四环生物：截至2026年8月20日，公司股东人数为67353
证券之星 · 08-27
四环生物：截至2026年8月20日，公司股东人数为67353
股市必读：四环生物中报 - 第二季度单季净利润同比下降349.66%
证券之星 · 08-24
股市必读：四环生物中报 - 第二季度单季净利润同比下降349.66%
四环生物（000518）2026年中报简析：净利润同比下降155.8%
证券之星 · 08-22
四环生物（000518）2026年中报简析：净利润同比下降155.8%
四环生物(000518)8月10日股东户数6.53万户，较上期增加1.85%
证券之星 · 08-21
四环生物(000518)8月10日股东户数6.53万户，较上期增加1.85%
暂无数据
公司概况
公司名称：
江苏四环生物股份有限公司
所属行业：
医药制造业
上市日期：
1993-09-08
主营业务：
江苏四环生物股份有限公司的主营业务是生物医药制品的生产和销售；苗木的种植、销售及绿化工程业务。公司的主要产品是生物药品、处方药。
发行价格：
2.50
{"stockData":{"symbol":"000518","market":"SZ","secType":"STK","nameCN":"四环生物","latestPrice":3.22,"timestamp":1793084610000,"preClose":3.35,"halted":0,"volume":23544100,"delay":0,"changeRate":-0.0388,"floatShares":1030000000,"shares":1030000000,"eps":-0.0514,"marketStatus":"已收盘","change":-0.13,"latestTime":"10-27 15:00:00","open":3.34,"high":3.36,"low":3.22,"amount":77153800,"amplitude":0.0418,"askPrice":3.23,"askSize":2290,"bidPrice":3.22,"bidSize":4288,"shortable":0,"etf":0,"ttmEps":-0.0514,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793151000000},"marketStatusCode":5,"adr":0,"adjPreClose":3.35,"symbolType":"stock","openAndCloseTimeList":[[1793064600000,1793071800000],[1793077200000,1793084400000]],"highLimit":3.69,"lowLimit":3.02,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":1029556222,"isCdr":false,"pbRate":11.17,"roa":"--","roe":"--","epsLYR":-0.036,"committee":0.379317,"marketValue":3315000000,"turnoverRate":0.0229,"status":1,"floatMarketCap":3315000000},"requestUrl":"/m/hq/s/000518/tweets","defaultTab":"tweets","newsList":[{"id":"2677946717","title":"四环生物（000518）10月23日主力资金净卖出1037.71万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677946717","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677946717?lang=zh_cn&edition=full","pubTime":"2026-10-23 15:32","pubTimestamp":1792740736,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月23日收盘，四环生物报收于3.44元，下跌3.91%，换手率4.18%，成交量43.08万手，成交额1.47亿元。10月23日的资金流向数据方面，主力资金净流出1037.71万元，占总成交额7.06%，游资资金净流入1035.09万元，占总成交额7.04%，散户资金净流入2.62万元，占总成交额0.02%。四环生物主营业务：主要从事生物医药制品的生产和销售以及园林绿化工程业务。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300023303.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0239","000518","BK0145","BK0046","BK0168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677625305","title":"四环生物（000518）10月21日主力资金净买入5402.45万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677625305","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677625305?lang=zh_cn&edition=full","pubTime":"2026-10-21 15:27","pubTimestamp":1792567662,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月21日收盘，四环生物报收于3.63元，上涨10.0%，换手率6.64%，成交量68.32万手，成交额2.42亿元。10月21日的资金流向数据方面，主力资金净流入5402.45万元，占总成交额22.28%，游资资金净流出3508.89万元，占总成交额14.47%，散户资金净流出1893.56万元，占总成交额7.81%。四环生物主营业务：主要从事生物医药制品的生产和销售以及园林绿化工程业务。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100021255.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0145","BK0168","BK0239","BK0086","BK0046","000518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677673649","title":"异动快报：四环生物（000518）10月21日11点13分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2677673649","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677673649?lang=zh_cn&edition=full","pubTime":"2026-10-21 11:15","pubTimestamp":1792552525,"startTime":"0","endTime":"0","summary":"证券之星10月21日盘中消息，11点13分四环生物（000518）触及涨停板。其所属行业生物制品目前上涨。领涨股为*ST未名。该股为园林，干细胞，医药概念热股，当日园林概念上涨1.26%，干细胞概念上涨0.96%，医药概念上涨0.8%。10月20日的资金流向数据方面，主力资金净流入773.15万元，占总成交额13.91%，游资资金净流出373.04万元，占总成交额6.71%，散户资金净流出400.11万元，占总成交额7.2%。近5日资金流向一览见下表：四环生物主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102100015471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","000518","BK0239","BK0046","BK0168","BK0145"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676578974","title":"股市必读：四环生物新发布《江苏四环生物股份有限公司关于收购吉林省长源药业有限公司部分股权的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2676578974","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676578974?lang=zh_cn&edition=full","pubTime":"2026-10-19 01:35","pubTimestamp":1792344910,"startTime":"0","endTime":"0","summary":"公司公告汇总：四环生物以现金16,000万元收购长源药业80%股权已完成工商变更，长源药业正式纳入公司合并报表范围。公司公告汇总江苏四环生物股份有限公司关于收购吉林省长源药业有限公司部分股权的进展公告江苏四环生物股份有限公司以现金16,000万元收购吉林省长源药业有限公司80%股权，本次交易已经公司第十一届董事会第五次会议及2026年第三次临时股东会审议通过。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900000490.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000518","BK0086","BK0168","BK0239","BK0145","BK0046"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2675751856","title":"四环生物（000518）披露收购长源药业部分股权进展公告，10月16日股价下跌2.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2675751856","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675751856?lang=zh_cn&edition=full","pubTime":"2026-10-16 22:33","pubTimestamp":1792161202,"startTime":"0","endTime":"0","summary":"截至2026年10月16日收盘，四环生物报收于3.29元，较前一交易日下跌2.08%，最新总市值为33.87亿元。近日，江苏四环生物股份有限公司发布《关于收购吉林省长源药业有限公司部分股权的进展公告》。公告显示，公司以现金16,000万元收购吉林省长源药业有限公司80%股权，本次交易已经公司第十一届董事会第五次会议及2026年第三次临时股东会审议通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101600040477.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","000518","BK0046","BK0145","BK0239","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2675366022","title":"股市必读：四环生物新发布《江苏四环生物股份有限公司关于收购中润药业有限公司部分股权的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2675366022","media":"证券之星","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675366022?lang=zh_cn&edition=full","pubTime":"2026-10-14 01:00","pubTimestamp":1791910841,"startTime":"0","endTime":"0","summary":"公司公告汇总江苏四环生物股份有限公司关于收购中润药业有限公司部分股权的进展公告江苏四环生物股份有限公司以现金16,000万元收购中润药业有限公司65.6146%股权，其中中润医药产业转让63.5963%股权，广东坤海转让2.0183%股权。中润药业已完成工商变更登记，公司持有其65.6146%股权；后续将对广东坤海和广东普润合计持有的17.9817%股权进行定向减资，减资完成后公司持股比例将增至80%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101400001193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","000518","BK0239","BK0168","BK0046","BK0145"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674822784","title":"四环生物（000518）10月12日主力资金净卖出2657.70万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674822784","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674822784?lang=zh_cn&edition=full","pubTime":"2026-10-12 15:33","pubTimestamp":1791790429,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月12日收盘，四环生物报收于3.4元，下跌5.56%，换手率2.72%，成交量27.96万手，成交额9741.12万元。10月12日的资金流向数据方面，主力资金净流出2657.7万元，占总成交额27.28%，游资资金净流入1106.83万元，占总成交额11.36%，散户资金净流入1550.86万元，占总成交额15.92%。四环生物主营业务：主要从事生物医药制品的生产和销售以及园林绿化工程业务。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200014970.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0046","000518","BK0086","BK0168","BK0145"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674849381","title":"股市必读：四环生物新发布《四环生物2026年第三次临时股东会法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2674849381","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674849381?lang=zh_cn&edition=full","pubTime":"2026-10-12 04:37","pubTimestamp":1791751028,"startTime":"0","endTime":"0","summary":"公司公告汇总：四环生物于2026年10月9日召开第三次临时股东会，审议通过《关于收购吉林省长源药业有限公司部分股权的议案》，同意股数占出席会议有表决权股份的99.5289%。江苏四环生物股份有限公司2026年第三次临时股东会决议公告江苏四环生物股份有限公司于2026年10月9日召开2026年第三次临时股东会，会议采用现场与网络投票相结合方式，出席股东及代理人共292人，代表有表决权股份373,671,043股，占公司股本总额的36.2944%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200001496.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","BK0145","BK0239","000518","BK0086","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674868551","title":"四环生物（000518）披露关于收购吉林省长源药业有限公司部分股权的议案获通过，10月09日股价下跌1.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674868551","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674868551?lang=zh_cn&edition=full","pubTime":"2026-10-09 22:52","pubTimestamp":1791557536,"startTime":"0","endTime":"0","summary":"截至2026年10月9日收盘，四环生物报收于3.6元，较前一交易日下跌1.1%，最新总市值为37.06亿元。近日，四环生物发布《2026年第三次临时股东会决议公告》显示，公司于2026年10月9日召开2026年第三次临时股东会，会议采用现场与网络投票相结合方式，出席股东及代理人共292人，代表有表决权股份373,671,043股，占公司股本总额的36.2944%。会议审议通过了《关于收购吉林省长源药业有限公司部分股权的议案》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900038846.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0145","BK0239","BK0046","000518","BK0168","BK0086"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670928287","title":"四环生物（000518）9月28日主力资金净买入729.07万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2670928287","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2670928287?lang=zh_cn&edition=full","pubTime":"2026-09-28 15:30","pubTimestamp":1790580627,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月28日收盘，四环生物报收于3.72元，上涨1.36%，换手率2.52%，成交量25.96万手，成交额9751.44万元。9月28日的资金流向数据方面，主力资金净流入729.07万元，占总成交额7.48%，游资资金净流入80.14万元，占总成交额0.82%，散户资金净流出809.2万元，占总成交额8.3%。四环生物主营业务：主要从事生物医药制品的生产和销售以及园林绿化工程业务。当天两者的差额即是当天两种力量相抵之后剩下的推动股价上升的净力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092800014628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0239","000518","BK0086","BK0145","BK0168"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669148464","title":"四环生物：第十一届董事会第五次会议决议公告","url":"https://stock-news.laohu8.com/highlight/detail?id=2669148464","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669148464?lang=zh_cn&edition=full","pubTime":"2026-09-23 21:32","pubTimestamp":1790170320,"startTime":"0","endTime":"0","summary":"证券日报网讯 9月23日，四环生物（维权）发布公告称，公司于2026年9月23日召开第十一届董事会第五次会议，本次会议审议通过《关于收购吉林省长源药业有限公司部分股权的议案》等多项议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-23/doc-inisvqcz1106664.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-23/doc-inisvqcz1106664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0046","000518","BK0239","BK0086","BK0168","BK0145"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669003291","title":"四环生物最新公告：拟1.6亿元收购长源药业80%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2669003291","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669003291?lang=zh_cn&edition=full","pubTime":"2026-09-23 18:50","pubTimestamp":1790160652,"startTime":"0","endTime":"0","summary":"四环生物(000518.SZ)公告称，公司拟以现金方式收购吉林省长源药业有限公司80%股权，交易价格为1.6亿元。本次交易完成后，长源药业将成为公司控股子公司。标的公司主要产品包括琥珀酰明胶注射液、脑栓康复胶囊等。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300034355.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000518","BK0168","BK0086","BK0046","BK0145","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669614121","title":"股市必读：四环生物新发布《四环生物2026年第二次临时股东会法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2669614121","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669614121?lang=zh_cn&edition=full","pubTime":"2026-09-23 02:30","pubTimestamp":1790101833,"startTime":"0","endTime":"0","summary":"公司公告汇总：2026年第二次临时股东会审议通过《关于收购中润药业有限公司部分股权的议案》，同意比例达99.6654%，已获三分之二以上通过。公司公告汇总四环生物2026年第二次临时股东会法律意见书江苏四环生物股份有限公司于2026年9月21日召开2026年第二次临时股东会，会议由董事会召集，采用现场与网络投票相结合方式举行。江苏世纪同仁律师事务所对本次会议出具了法律意见书，认为会议召集、召开程序及表决结果合法有效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092300002761.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0046","BK0239","000518","BK0168","BK0145"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669148745","title":"四环生物（000518）披露收购中润药业部分股权议案获临时股东大会通过，9月22日股价下跌2.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2669148745","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669148745?lang=zh_cn&edition=full","pubTime":"2026-09-22 17:46","pubTimestamp":1790070388,"startTime":"0","endTime":"0","summary":"截至2026年9月22日收盘，四环生物报收于3.78元，较前一交易日下跌2.33%，最新总市值为38.92亿元。公司于近日披露《江苏四环生物股份有限公司2026年第二次临时股东会决议公告》。公告显示，江苏四环生物股份有限公司于2026年9月21日召开2026年第二次临时股东会，会议采用现场与网络投票相结合方式召开，出席股东及代理人共397名，代表有表决权股份375,446,635股，占公司股本总额的36.4668%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092200031317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0145","BK0168","BK0046","BK0239","BK0086","000518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664370263","title":"四环生物：公司将于2026年9月21日召开2026年第二次临时股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2664370263","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664370263?lang=zh_cn&edition=full","pubTime":"2026-09-04 21:22","pubTimestamp":1788528120,"startTime":"0","endTime":"0","summary":"证券日报网讯9月4日，四环生物（维权）发布公告称，公司将于2026年9月21日召开2026年第二次临时股东会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-04/doc-iniqsran0812294.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-09-04/doc-iniqsran0812294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0145","BK0168","BK0086","BK0239","000518","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664104336","title":"四环生物最新公告：拟1.6亿元收购中润药业65.61%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2664104336","media":"证券之星","labels":["shareholding","merge"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664104336?lang=zh_cn&edition=full","pubTime":"2026-09-04 18:49","pubTimestamp":1788518983,"startTime":"0","endTime":"0","summary":"四环生物(000518.SZ)公告称，公司拟以现金1.6亿元收购中润药业65.6146%股权，交易完成后中润药业将成为控股子公司。同时，中润药业将向定向减资方定向减少17.9817%股权，不支付减资对价，减资完成后公司将持有其80%股权。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090400035418.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,merge","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0086","BK0168","BK0239","000518","BK0145","BK0046"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662700693","title":"四环生物：截至2026年8月20日，公司股东人数为67353","url":"https://stock-news.laohu8.com/highlight/detail?id=2662700693","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662700693?lang=zh_cn&edition=full","pubTime":"2026-08-27 20:51","pubTimestamp":1787835087,"startTime":"0","endTime":"0","summary":"证券之星消息，四环生物(000518)08月26日在投资者关系平台上答复投资者关心的问题。投资者提问：请问8月20日股东人数是多少？谢谢四环生物回复：投资者您好，截至2026年8月20日，公司股东人数为67353。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：刘浩然","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700051293.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0046","BK0086","BK0239","BK0168","BK0145","000518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661061243","title":"股市必读：四环生物中报 - 第二季度单季净利润同比下降349.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661061243","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661061243?lang=zh_cn&edition=full","pubTime":"2026-08-24 01:25","pubTimestamp":1787505912,"startTime":"0","endTime":"0","summary":"业绩披露要点：2026年第二季度单季度归母净利润为-1451.94万元，同比下降349.66%。业绩披露要点财务报告2026年中报显示，上半年度公司主营收入1.11亿元，同比下降39.12%；归母净利润-2583.32万元，同比下降155.8%；扣非净利润-2817.44万元，同比下降135.59%；其中2026年第二季度单季度主营收入2957.22万元，同比下降78.58%；单季度归母净利润-1451.94万元，同比下降349.66%；单季度扣非净利润-1446.16万元，同比下降318.89%；负债率28.0%，投资收益0.0万元，财务费用49.65万元，毛利率20.57%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400000891.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661388218","title":"四环生物（000518）2026年中报简析：净利润同比下降155.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661388218","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661388218?lang=zh_cn&edition=full","pubTime":"2026-08-22 06:08","pubTimestamp":1787350082,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期四环生物发布2026年中报。根据财报显示，四环生物净利润同比下降155.8%。截至本报告期末，公司营业总收入1.11亿元，同比下降39.12%，归母净利润-2583.32万元，同比下降155.8%。按单季度数据看，第二季度营业总收入2957.22万元，同比下降78.58%，第二季度归母净利润-1451.94万元，同比下降349.66%。投资活动产生的现金流量净额变动幅度为-310.85%,原因:报告期因处置子公司收到的现金同比减少。本文数据来源于四环生物2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082200004902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000518"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661269416","title":"四环生物(000518)8月10日股东户数6.53万户，较上期增加1.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661269416","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661269416?lang=zh_cn&edition=full","pubTime":"2026-08-21 17:40","pubTimestamp":1787305247,"startTime":"0","endTime":"0","summary":"证券之星消息，近日四环生物披露，截至2026年8月10日公司股东户数为6.53万户，较7月31日增加1186.0户，增幅为1.85%。在生物制品行业个股中，四环生物股东户数高于行业平均水平，截至8月10日，生物制品行业平均股东户数为3.53万户。从股价来看，2026年7月31日至2026年8月10日，四环生物区间涨幅为14.4%，在此期间股东户数增加1186.0户，增幅为1.85%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100032364.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0168","000518","BK0046","BK0145","BK0239","BK0086"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793129844042,"stockEarnings":[{"period":"1week","weight":-0.0242},{"period":"1month","weight":-0.1226},{"period":"3month","weight":-0.1006},{"period":"6month","weight":0.1065},{"period":"1year","weight":0.2984},{"period":"ytd","weight":0.3361}],"compareEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.0471},{"period":"6month","weight":-0.1128},{"period":"1year","weight":-0.0872},{"period":"ytd","weight":-0.0808}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏四环生物股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"61774人(较上一季度减少0.59%)","perCapita":"16666股","listingDate":"1993-09-08","address":"江苏省无锡市江阴市滨江东路2号41楼05、06座","registeredCapital":"102955万元","survey":" 江苏四环生物股份有限公司的主营业务是生物医药制品的生产和销售；苗木的种植、销售及绿化工程业务。公司的主要产品是生物药品、处方药。","listedPrice":2.5},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"四环生物(000518)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供四环生物(000518)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"四环生物,000518,四环生物股票,四环生物股票老虎,四环生物股票老虎国际,四环生物行情,四环生物股票行情,四环生物股价,四环生物股市,四环生物股票价格,四环生物股票交易,四环生物股票购买,四环生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"四环生物(000518)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供四环生物(000518)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}